Presentation TCT 2017

Rationale and Studies of P2Y12 Inhibitor Monotherapy

Presenter: Roxana Mehran

October 30, 2017

REGISTER for free or LOG IN to view this content

Rationale and Studies of P2Y12 Inhibitor Monotherapy

Coronary

Presentation

TCT 2017

CAD Pharma

Up Next

Presentation TCT 2017

Impella and Rotablation-assisted Bifurcation PCI Following Previous Edwards SAPIEN 3 TAVR

Presenter: Faisal Khan

October 30, 2017

More slides +

Presentation TCT 2017

Malposition of the Evolut R Bioprosthesis During TAVR

Presenter: Tomasz Gasior

October 30, 2017

Presentation TCT 2017

Evaluation of Suspected Coronary Artery Disease With Noninvasive and Invasive Imaging: What Do the Data and EU Guidelines Say?

Presenter: Stephan Achenbach

October 30, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.